Uma Sinha's Net Worth
$3.79 Million
Who is Uma Sinha?
Uma Sinha has an estimated net worth of $3.79 Million. This is based on reported shares across multiple companies, which include BridgeBio Pharma, Inc., PROKIDNEY CORP., and Eidos Therapeutics, Inc..
SEC CIK
Uma Sinha's CIK is 0001742587
Past Insider Trading and Trends
2020 was Uma Sinha's most active year for acquiring shares with 12 total transactions. Uma Sinha's most active month to acquire stocks was the month of April. 2020 was Uma Sinha's most active year for disposing of shares, totalling 12 transactions. Uma Sinha's most active month to dispose stocks was the month of December. 2019 saw Uma Sinha paying a total of $259,246.57 for 15,769 shares, this is the most they've acquired in one year. In 2021 Uma Sinha cashed out on 373,525 shares for a total of $1,243,178.85, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BridgeBio Pharma, Inc. (BBIO) Snapshot price: $30.7
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
| +2.93% | 469 |
—
|
—
| 16.46K |
Nov 16
| |||
Form 4
| +3.01% | 468 |
—
|
—
| 15.99K |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +10.88% | 1.52K |
—
|
—
| 15.52K |
May 19
| |||
Form 4
|
∞
| 14K |
$17.00 | $238,000.00 | 14K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PROKIDNEY CORP. (PROK) Snapshot price: $2.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Jul 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eidos Therapeutics, Inc. No price found
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -306.52K |
—
|
—
|
0
|
Oct 27 - Jan 26
| |||
Form 4
| -3.16% | -10.00K |
$124.32 | -$1,243,178.85 | 306.52K |
Scheduled
|
Jan 13
| ||
Form 4
| -1.56% | -5.00K |
$90.04 | -$450,187.20 | 316.52K |
Scheduled
|
Dec 2
| ||
Form 4
| -1.53% | -5.00K |
$72.42 | -$362,099.04 | 321.52K |
Scheduled
|
Oct 29
| ||
Form 4
| -1.51% | -5.00K |
$52.34 | -$261,716.66 | 326.52K |
Scheduled
|
Sep 30 - Oct 1
| ||
Form 4
| +0.13% | 444 |
$41.57 | $18,458.63 | 331.52K |
May 31
| |||
Form 4
| -3.64% | -12.50K |
$61.90 | -$773,793.53 | 331.08K |
Dec 18
| |||
Form 4
| -0.72% | -2.50K |
$38.41 | -$96,016.44 | 343.58K |
Sep 25
| |||
Form 4
| -0.92% | -3.23K |
$24.07 | -$159,380.56 | 346.08K |
May 31 - Jul 25
| |||
Form 4
| -1.11% | -3.92K |
$19.65 | -$123,393.19 | 349.31K |
Nov 30 - May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||